1. NeuroCure Clinical Research Center NCRC, Charité – Universitätsmedizin Berlin, Berlin, Germany/Institute for Medical Immunology, Experimental Neuroimmunology, Charité – Universitätsmedizin Berlin, Germany
2. NeuroCure Clinical Research Center NCRC, Charité – Universitätsmedizin Berlin, Berlin, Germany
3. Institute for Medical Immunology, Experimental Neuroimmunology, Charité – Universitätsmedizin Berlin, Germany
4. Institute for Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology, University Medical Center-Eppendorf, Hamburg, Germany
5. NeuroCure Clinical Research Center NCRC, Charité – Universitätsmedizin Berlin, Berlin, Germany/Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany
6. Department of Neurology, Charité – Universitätsmedizin Berlin, Germany
7. NeuroCure Clinical Research Center NCRC, Charité – Universitätsmedizin Berlin, Berlin, Germany/Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany/Department of Neurology, Charité – Universitätsmedizin Berlin, Germany